The US Supreme Court is expected to closely scrutinize a federal appeals court’s rationale for allowing doctors to proceed with a lawsuit that’s limited access to abortion pills.
A panel of appeals court judges late Wednesday significantly narrowed a federal trial court ruling in Texas that would potentially prohibit the use of mifepristone altogether, instead blocking more recent changes making the drug more widely available while appeals continue.
The US Court of Appeals for the Fifth Circuit said doctors suing to block the drug had standing to sue, in part because they may someday have to treat patients who experience ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.